Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
Recruiting · NCT03445949 · Registry updated 2023-07-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure | Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 4 | 2023-07-11 | NCT03445949 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical Research Agency, Poland | 33 |
| National Institute of Cardiology, Warsaw, Poland | 14 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institute of Cardiology | Warsaw | Poland | 2 |